ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009

NCI Advisory Group, Other Cancer Meetings For September, October

August 27, 1976

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997

NCI Advisory Group, Other Cancer Meetings

February 28, 1986